Head-up tilt test: Is it essential for an appropriate treatment of vasovagal syncope? Arguments against;Test de mesa basculante: ¿es imprescindible para el tratamiento adecuado del síncope vasovagal? Argumentos en contra

Revista Espanola de Cardiologia

Volumn 50, Issue 6, 1997, Pages 374-382

  Ruiz Granell, Ricardo ^a,b   García Civera, Roberto ^a   Morell Cabedo, Salvador ^a   Botella Solana, Segismundo ^a   López Merino, Vicente ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b NONE   (Spain)

Author keywords

Diagnostic value; Neurocardiogenic syncope; Tilt test; Treatment; Vasovagal syncope

Indexed keywords

HUMAN; REVIEW; SYNCOPE; TILT TABLE TEST;

HUMANS; SYNCOPE, VASOVAGAL; TILT-TABLE TEST;

EID: 0031159468     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(97)73239-1     Document Type: Article

References (98)

1. Llavador J, Morell S, Muñoz J, Ros D, Sanjuán R. Síncope. Concepto y evolución histórica. En: Garcia Civera R, Sanjuán R, Cosín J, López Merino V, editores. Síncope. Barcelona: MCR, 1989; 3-9.
2. Sutton R, Fitzpatrick A. Valor diagnóstico de las pruebas con tabla basculante. En: García Civera R, Sanjuán R, Cosía J, López Merino V, editores. Síncope. Barcelona: MCR, 1989; 135-140.
3. Von Bezold A, Hirt L. Über die physiologishen Wirkungen des essigsauren Veratrins. Untersuchungen aus dem physiologishen laboratorium in Würzburg 1867; 1: 75-156.
4. Jarisch A, Henze C. Über blutdrucksenkung durch chemische erregung depressorischer nerven. Nauyn-Schmiedebergs Archiv für experimentale Pathologie und Pharmacologia 1937; 187: 706-730.
5. Jarisch A, Zotterman Y. Depressor reflexes from the heart. Acta Physiol Scand 1948; 16: 31-51.
6. García Civera R, Ruiz Granell R, Sanjuán R, Morell S, Fenollar JV, Burguera MA et al. Síncope vasovagal. Fisiopatología, diagnóstico y tratamiento. Rev Esp Cardiol 1993; 46: 648-658.
7. García Civera R, Ruiz Granell R, Cosín J, López Merino V. Síncope vasovagal. En: García Civera R, Sanjuán R, Cosín J, López Merino V, editores. Síncope. Barcelona: MCR, 1989; 177-198.
8. Lewis T. A lecture on vasovagal syncope and the carotid sinus mechanism: with comments on Gower's and Nothnangel's syndrome. Br Med J 1932; 1: 873-876.
9. Jarish A. Vasovagale syncope. Z Kreisl Forsch 1941; 23: 267-279.
10. Kosinski D, Grubb BP, Temesy-Armos P. Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives. PACE 1995; 18: 716-724.
11. Sutton R, Petersen MEV. The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Electrophysiol 1995; 6: 569-576.
12. a ed.). Filadelfia: WB Saunders Co., 1997; 863-876.
13. Abboud FM. Neurocardiogenic syncope. N Engl J Med 1993; 328: 1.117-1.120.
14. Hellebrandt FA, Franseen EB. Physiologic study of vertical stance in man. Physiol Rev 1943; 23: 220-225.
15. Grabyel A, McFarland RA. The use of the tilt table in aviation medicine. J Aviation Med 1941; 12: 194-211.
16. McMichael J, Sharpey-Schafer EP. Cardiac output in man by the direct Fick method: effects of posture, venous pressure change, atropine and adrenaline. Br Heart J 1944; 6: 33-40.
17. Allen SC, Taylor CL, Hall VE A study of orthostatic insufficiency by the tiltboard method. Am J Physiol 1945; 143: 11-20.
18. Stevens P. Cardiovascular dynamics during orthostasis and the influence of vascular instrumentation. Am J Cardiol 1966; 17: 211-218.
19. Bridgen W, Howard S, Sharpey-Schafer EP. Postural changes in peripheral blood-flow of normal subjects with observations on vasovagal fainting reactions as results of tilting, the lordotic posture, pregnancy and spinal anaesthesia. Clin Sci 1950; 9: 79-91.
20. Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986; 1: 1.352-1.354.
21. Tavill CM, Sutton R, Vardas P, Ingram A. Incidence of malignant vasovagal syndrome in patients presenting with syncope. New Trends In Arrhythmias 1988; 4: 769-774.
22. Fitzpatrick A, Theodorakis G, Vardas PTI, Kenny RA, Travill CM, Ingram A et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J 1991; 12: 389-394.
23. Abi-Samra F, Maloney JD, Fouad-Tarazi FM, Castle LW. Head-up tilt testing: an important tool in the work-up of recurrent syncope of unknown etiology [resumen]. J Am Coll Cardiol 1986; 7: 126.
24. Abi-Samra F, Maloney JD, Fouad-Tarazi FM, Castle LW. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. PACE 1988; 11: 1.202-1.214.
25. Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla ATI. Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol 1991; 68: 1.032-1.036.
26. McIntosh S, Da Costa D, Kenny RA. Outcome of an integrated approach to the investigation of dizziness, falls and syncope in elderly patients referred to a «syncope» clinic. Age Ageing 1993; 22: 53-58.
27. Alboni P, Menozzi C, Brignole M, Paparella N, Lolli G, Oddone DTI et al. An abnormal neural reflex plays a role in causing syncope in sinus bradycardia. J Am Coll Cardiol 1993; 22: 1.130-1.134.
28. Rowe PC, Bou-Holaigah I, Kan JS, Calkins HTI. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 1995; 345: 623-624.
29. Bou-Holaigah I, Rowe PC, Kan J, Calkins HTI. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995; 274: 961-967.
30. Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB et al. ACC Expert Consensus Document. Tilt table for assessing syncope. J Am Coll Cardiol 1996; 28: 263-275.
31. Almqvist A, Goldenberg IF, Milstein S, Chen MY, Chen XC, Hansen R et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989; 320: 346-351.
32. De Mey C, Enterling D. Variant responses impair the usefulness of passive upright tilt in drug research. Methods Find Exp Clin Pharmacol 1988; 10: 57-64.
33. Strasberg B, Rechavia E, Sagie A, Kusniec J, Mager A, Sclarovsky S et al. The head-up tilt table test in patients with syncope of unknown origin. Am Heart J 1989; 118: 923-927.
34. Pongiglione G, Fish FA, Strasburger JF, Benson DW Jr. Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope. J Am Coll Cardiol 1990; 16: 165-170.
35. Raviele A, Gasparini G, Di Pede F, Delise P, Bonso A, Piccolo E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 1990; 65: 1.322-1.327.
36. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17: 125-130.
37. Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med 1992; 116: 358-363.
38. Sheldon R, Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol 1992; 19: 773-779.
39. Fouad FM, Sitthisook S, Vanerio G, Maloney J III, Okabe M, Jaeger F et al. Sensitivity and specificity of the tilt table test in young patients with unexplained syncope. PACE 1993; 16: 394-400.
40. Newman D, Lurie K, Rosenqvist M, Washington C, Schwartz J, Scheinman MM. Head-up tilt testing with and without isoproterenol infusion in healthy subjects of different ages. PACE 1993; 16: 715-721.
41. Morillo CA, Klein GJ, Zandri S, Yee R. Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J 1995; 129: 901-906.
42. Natale A, Akhtar M, Jazayeri M, Dhala A, Blanck Z, Deshpande S et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 1995; 92: 54-58.
43. Raviele A, Gasparini G, Di Pede F, Menozzi C, Brignole M, Dinelli M et al. Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J 1994; 127: 103-111.
44. Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995; 76: 267-272.
45. Lurie KG, Dutton J, Mangat R, Newman D, Eisenberg S, Scheinman M. Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing. Am J Cardiol 1993; 72: 1.286-1.290.
46. Ovadia M, Thoele D. Esmolol tilt testing with esmolol withdrawal for the evaluation of syncope in the young. Circulation 1994; 89: 228-235.
47. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 1994; 97: 78-88.
48. Waxman MB, Yao L, Cameron DA, Wald RW, Roseman J. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. Am J Cardiol 1989; 63: 58-65.
49. Calkins H, Kadish A, Sousa J, Rosenheck S, Morady F. Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope. Am J Cardiol 1991; 67: 207-209.
50. Moya i Mitjans A, Permanyer Miralda G, Sagrista Sauleda J, Mont Girbau L, Rius Gelabert T, Soler Soler J. Análisis de las respuestas a la prueba en tabla basculante en función de las características clínicas de los episodios sincopales en pacientes sin cardiopatía aparente. Rev Esp Cardiol 1993; 46: 214-219.
51. McIntosh SJ, Lawson J, Kenny RA. Intravenous cannulation alters the specificity of head-up tilt testing for vasovagal syncope in elderly patients. Age Ageing 1994; 23: 317-319.
52. De-Jong-de-Vos-van-Steenwijk CC, Wieling W, Johannes JM, Harms MP, Kuis W, Wesseling KH. Incidence and hemodynamic characteristics of near-fainting in healthy 6- to 16-year old subjects. J Am Coll Cardiol 1995; 25: 1.615-1.621.
53. Lipsitz LA, Marks ER, Koestner J, Jonsson PV, Wei JY. Reduced susceptibility to syncope during postural tilt in old age. Is beta-blockade protective? Arch Intern Med 1989; 149: 2.709-2.712.
54. Sheldon R. Effects of aging on responses to isoproterenol tilt-table testing in patients with syncope. Am J Cardiol 1994; 74: 459-463.
55. Sheldon R, Splawinski J, Killam S. Reproducibility of isoproterenol tilt-table tests in patients with syncope. Am J Cardiol 1992; 69: 1.300-1 305.
56. Grubb BP, Wolfe D, Temesy Armos P, Hahn H, Elliott L. Reproducibility of head upright tilt table test results in patients with syncope. PACE 1992; 15: 1.477-1.481.
57. De Buitleir M, Grogan EW Jr, Picone MF, Casteen JA. Immediate reproducibility of the tilt-table test in adults with unexplained syncope. Am J Cardiol 1993; 71: 304-307.
58. Brooks R, Ruskin JN, Powell AC, Newell J, Garan H, McGovern BA. Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 1993; 71: 1.289-1.292.
59. Ruiz GA, Scaglione J, Gonzalez Zuelgaray J. Reproducibility of head-up tilt test in patients with syncope. Clin Cardiol 1996; 19: 215-220.
60. Chen XC, Chen MY. Remole S, Kobayashi Y, Dunnigan A, Milstein S et al. Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol 1992; 69: 755-760.
61. Fish FA, Strasburger JF, Benson DW Jr. Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope. Am J Cardiol 1992; 70: 605-609.
62. Blanc JJ, Mansourati J, Maheu B, Boughaleb D, Genet L. Reproducibility of a positive passive upright tilt test at a seven-day interval in patients with syncope. Am J Cardiol 1993; 72: 469-471.
63. Morillo CA, Leitch JW, Yee R, Klein GJ. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993; 22: 1.843-1.848.
64. Moya A, Permanyer Miralda G, Sagristá Sauleda J, Carné X, Rius T, Mont L et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 1995; 25: 65-69.
65. Natale A, Sra J, Dhala A, Wase A, Jazayeri M, Deshpande S et al. Efficacy of different treatment strategies for neurocardiogenic syncope. PACE 1995; 18: 655-662.
66. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996; 93: 973-981.
67. Natale A, Geiger MJ, Maglio C, Newby KH, Dhala A, Akhtar M et al. Recurrence of neurocardiogenic syncope without pharmacologic interventions. Am J Cardiol 1996; 77: 1.001-1.003.
68. Ruiz GA, Peralta A, Gonzalez Zuelgaray J, Duce E. Evolution of patients with clinical neurocardiogenic (vasovagal) syncope not subjected to specific treatment. Am Heart J 1995; 130: 345-350.
69. Fitzpatrick A, Theodorakis G, Ahmed R, Williams T, Sutton R. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degrees tilt. PACE 1991; 14: 13-19.
70. Grubb BP, Temesy-Armos P, Moore J, Wolfe D, Hahn H, Elliot L. Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome. Am J Cardiol 1992; 69: 904-908.
71. Petersen ME, Chamberlain Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994; 71: 274-281.
72. Sra JS, Jazayeri MR, Avitall B, Dhala A, Deshpande S, Blanck Z et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993; 328: 1.085-1.090.
73. Petersen ME, Price D, Williams T, Jensen N, Riff K, Sutton R. Short AV interval VDD pacing does not prevent tilt induced vasovagal syncope in patients with cardioinhibitory vasovagal syndrome. PACE 1994; 17: 882-891.
74. Benditt DG, Petersen M, Lurie KG, Grubb BP, Sutton R. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med 1995; 122: 204-209.
75. Sra JS, Akhtar M. Cardiac pacing during neurocardiogenic (vasovagal) syncope. J Cardiovasc Electrophysiol 1995; 6: 751-760.
76. Grubb BP, Temesy-Armos P, Hahn H, Elliott L. Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin. Am J Med 1991; 90: 6-10.
77. Blanc JJ, Corbel C, Mansourati J, Genet L. Evaluation du traitement betabloquant dans les syncopes vasovagales reproduites par le test d'inclinaison. Arch Mal Coeur Vaiss 1991; 84: 1.453-1.457.
78. Lopez Candel J, Picó Aracil F, Sánchez Muñoz JJ, De la Morena G, Martínez Sánchez J, Salas J et al. Síncope vasovagal maligno: diagnóstico y ensayo terapéutico basado en el test de ortostatismo (test de TILT). Rev Esp Cardiol 1993; 46: 28-33.
79. Balaji S, Oslizlok PC, Allen MC, McKay CA, Gillette PC. Neurocardiogenic syncope in children with a normal heart. J Am Coll Cardiol 1994; 23: 779-785.
80. Scott WA, Pongiglione G, Bromberg BI, Schaffer MS, Deal BJ, Fish FA et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 1995; 76: 400-402.
81. Cox MM, Perlman BA, Mayor MR, Silberstein TA, Levin E, Pringle L et al. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 1995; 26. 1.293-1.298.
82. Sra JS, Murthy VS, Jazayeri MR, Shen YH, Troup PJ, Avitall B et al. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 1992; 19: 402-408.
83. Muller G, Deal BJ, Strasburger JF, Benson DW Jr. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am J Cardiol 1993; 71: 592-595.
84. Jhamb DK, Singh B, Sharda B, Kaul U, Goel P, Talwar KK et al. Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response. Am Heart J 1996; 132: 608-611.
85. Cohen MB, Snow JS, Grasso V, Lehnen L, Goldner BG, Jadonath RL et al. Efficacy of pindolol for treatment of vasovagal syncope. Am Heart J 1995; 130: 786-790.
86. Pérez Paredes M, Picó Aracil F, Ruipérez Abizanda JA, Martínez Sánchez J, Florenciano Sánchez R, Ruiz Martínez F et al. Uso de la escopolamina transdérmica en la prevención del síncope neurocardiogénico inducido mediante test de basculación. Rev Esp Cardiol 1995; 48: 480-485.
87. Strieper MJ, Campbell RM. Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope. J Am Coll Cardiol 1993; 22: 594-597.
88. Milstein S, Buetikofer J, Dunnigan A, Benditt DG, Gornick C, Reyes WJ. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 1990; 65: 1.339-1.344.
89. Kelly PA, Mann DE, Adler SW, Fuenzalida CE, Reiter MJ. Low dose disopyramide often fails to prevent neurogenic syncope during head-up tilt testing. PACE 1994; 17: 573-576.
90. Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliott L. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. PACE 1993; 16: 458-464.
91. Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994; 24: 490-494.
92. Grubb BP, Kosinski D, Mouhaffel A, Pothoulakis A. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. PACE 1996; 19: 836-840.
93. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992; 70: 339-342.
94. Lee TM, Su SF, Chen MF, Liau CS, Lee YT. Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 1996; 78: 480-482.
95. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996; 78: 536-539.
96. Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K et al. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995; 130: 1.250-1.253.
97. VASIS Group. Double-blind randomized study of etilefrine versus placebo in patients with tilt-induced recurrent vasovagal syncope. Eur J Card Pacing Electrophysiol 1993; 2: 164-168.
98. VASIS Group. Is dual-chamber pacing efficacious in treatment of neurally mediated tilt positive cardioinhibitory syncope?. Pacemaker vs no therapy: a multicenter randomized study. Eur J Card Pacing Electrophysiol 1993; 2: 169-172.